Omnilink Elite 1012630-39Recalls & reported problems
Abbott Vascular Inc. · Omnilink Elite Vascular Balloon-Expandable Stent System 7.0 mm x 39 mm x 135 cm Over-The-Wire · Class 3 · Implant
All models of Omnilink Elite (42)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08717648178474), received between Apr 15, 2019 and Sep 15, 2022 — classified as 3 injuries.
The most frequently reported specific device problem is “Device Dislodged or Dislocated” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Device Dislodged or Dislocated2
- Difficult to Remove2
- Failure to Advance2
- Migration1
Patient problems
- Embolism/Embolus1
- No Clinical Signs, Symptoms or Conditions1
- Vessel Or Plaque, Device Embedded In1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjurySep 15, 2022Migration; Migration
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT THE LEFT ILIAC ARTERY WITH CALCIFICATION AND 70% STENOSIS. INTRAVASCULAR ULTRASOUND WAS PERFORMED AND A 6FR 10 CM SHEATH WAS USED. THE 7.0X39 MM OMNILINK ELITE STENT DELIVERY SYSTEM (SDS) WAS INFLATED TO NOMINAL PRESSURE AND IT WAS THOUGHT TO HAVE DEPLOYED THE STENT; HOWEVER, SOMETHING WAS NOTICED FLOATING IN THE AORTA AND IT WAS DETERMINED TO BE THE STENT. THE STENT DISLODGED [MIGRATED] INTO THE AORTA ONCE DEFLATION WAS COMPLETED. THERE WERE NO ISSUES NOTED DURING INFLATION OR DEFLATION AND THERE WAS NO RESISTANCE DURING ADVANCEMENT. A SNARE WAS USED TO RETRIEVE THE STENT FROM THE AORTA THRU THE OTHER GROIN. ANOTHER OMNILINK ELITE SDS WAS USED TO COMPLETE THE PROCEDURE. THERE WERE NO ADVERSE PATIENT SEQUELA AND THERE WAS A DELAY IN THE PROCEDURE, BUT THERE WAS NO IMPACT TO THE PATIENT. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15432671 ↗InjuryAug 22, 2022Difficult to Remove; Failure to Advance; Device Dislodged or Dislocated; Difficult to Remove; Failure to Advance; Device Dislodged or Dislocated
IT WAS REPORTED THAT THE PROCEDURE WAS PERFORMED EMERGENTLY, TREATING RIGHT LEG PAIN. THE TARGET LESION WAS IN THE RIGHT ILIAC ARTERY, VIA LEFT COMMON FEMORAL ACCESS. THE OMNILINK ELITE STENT DELIVERY SYSTEM WAS ADVANCED, BUT WAS UNABLE TO TRAVERSE THE BIFURCATION, DUE TO SEVERE CALCIFICATION. THE DECISION WAS MADE TO TRY ACCESS VIA THE RIGHT COMMON FEMORAL ARTERY; HOWEVER, THE DEVICE WAS STILL UNABLE TO CROSS. ACCESS THEN ATTEMPTED VIA THE RIGHT RADIAL ARTERY. THE TARGET LESION WAS BALLOONED WITH AN UNSPECIFIED DILATATION CATHETER AND THE OMNILINK WAS ADVANCED; HOWEVER, THE DEVICE WAS STILL UNABLE TO CROSS THE TARGET LESION. ONLY THE FRONT PORTION OF THE OMNILINK WAS ABLE TO CROSS. THE DECISION MADE TO ADVANCE A NON-ABBOTT SHEATH; HOWEVER, THE SHEATH BECAME CAUGHT ON THE PROXIMAL EDGE OF THE STENT. THE PHYSICIAN TRIED TO PULL THE STENT DELIVERY SYSTEM INTO THE SHEATH; HOWEVER, THE STENT DISLODGED AND EMBOLIZED TO THE RIGHT COMMON FEMORAL ARTERY. AN ATTEMPT WAS MADE TO SNARE THE DISLODGED STENT; BUT THIS WAS NOT POSSIBLE. THE STENT REMAINED IN THE COMMON FEMORAL ARTERY AND A CUT-DOWN PROCEDURE WAS PERFORMED. THE STENT WAS ABLE TO BE REMOVED. A PATCH WAS PLACED ON THE RIGHT COMMON F
Patient problems: Embolism/Embolus
MAUDE report 15272334 ↗InjuryApr 15, 2019Difficult to Remove; Failure to Advance; Device Dislodged or Dislocated; Difficult to Remove; Failure to Advance; Device Dislodged or Dislocated
IT WAS REPORTED THAT THE PROCEDURE WAS PERFORMED TO TREAT A MILDLY TORTUOUS AND MODERATELY CALCIFIED LESION IN THE COMMON ILIAC ARTERY. THE VESSEL WAS NOT PRE-DILATED. A 7.0X39MM OMNILINK ELITE OTW STENT DELIVERY SYSTEM (SDS) WAS ADVANCED BUT WOULD NOT CROSS THE TARGET LESION. THE SDS THEN BECAME STUCK WITH THE ANATOMY AND THE STENT DISLODGED FROM THE BALLOON IN THE COMMON ILIAC ARTERY. THE SDS WAS REMOVED, AND ANOTHER OMNILINK SDS WAS THEN ADVANCED AND THE STENT WAS DEPLOYED TO CRUSH THE DISLODGED OMNILINK STENT INTO THE VESSEL WALL, WITHIN THE TARGET LESION, AND THE PROCEDURE CONCLUDED. THERE WAS NO ADVERSE PATIENT SEQUELA, AND THERE WAS NO REPORTED CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Vessel Or Plaque, Device Embedded In
MAUDE report 8514246 ↗
Other STENT, ILIAC devices
- Cordis S.M.A.R.T. Control Vascular Stent System C10040MLCordis US Corp. · STENT, ILIAC1 recall3 reports
- Absolute Pro 1012534-100Abbott Vascular Inc. · STENT, ILIAC51 reports
- Cordis S.M.A.R.T. Control Vascular Stent System C09060MLCordis US Corp. · STENT, ILIAC1 recall0 reports
- Protégé™ GPS™ SERB65-09-60-80Ev3, Inc · STENT, ILIAC1 recall0 reports
- Absolute Pro 1012535-100Abbott Vascular Inc. · STENT, ILIAC1 death41 reports
- Omnilink Elite 1012631-39Abbott Vascular Inc. · STENT, ILIAC27 reports
- Omnilink Elite 1012632-29Abbott Vascular Inc. · STENT, ILIAC25 reports
- Omnilink Elite 1012631-59Abbott Vascular Inc. · STENT, ILIAC21 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page